Meet BacVax: a PBC startup working on a vaccine to prevent ear infections in young children.
Dr. Terrence Stull’s company, called BacVax, is developing a vaccine to prevent ear infections in young children.
BacVax is a University of Arizona spinoff founded by Stull, former senior vice president of research at Phoenix Children’s Hospital.
BacVax uses molecular genetics to study Haemophilus influenzae, a common cause of ear infections. Stull moved his startup from the University of Arizona College of Medicine – Phoenix to 850 PBC on the Phoenix Bioscience Core in July 2021, noting the building is a prime location to grow and expand.
Related reading:
Check out the new Connect Labs at 850 PBC, opening in just a few short weeks.
Check out the video below and read more about BacVax here on the Arizona PBS website as part of its Health Tomorrow segment, supported by the Phoenix Bioscience Core.
More news from the PBC
- Helios Scholars at TGen Celebrates 20 Years of Investment in Arizona’s Future Scientists
- NAU’s College of Health and Human Services students present at the National Conference of Undergraduate Research
- For First Time, Graduate Programs Honored with the Pathway Scholars Students
- Picard Medical / SynCardia Advances Emperor Total Artificial Heart Program with Successful Next-Generation Preclinical Implant Studies
- 11th Annual ABRC-Flinn Research Conference a Platform for Important Breakthroughs in Medicine
- Fashion and Philanthropy Unite to Advance Women’s Cancer Research at Runway for Research 2026
- Meet the 2026 Undergraduate Interns at Barrow